Collaborative Practice Agreement · PharmD

District of Columbia Collaborative Practice Agreement for Pharmacists

Required. The Collaborative Practice Agreement is the written instrument District of Columbia law names for a Pharmacist working with a physician. Below: the board that governs it, what it must contain, and the terms it has to carry.

Practice authoritySupervision required
Written agreementAgreement required
What District of Columbia calls itCollaborative Practice Agreement
Governing boardDC Board of Pharmacy
Agreement familyCollaborative Practice
Research date2026-09-03 · clauses 2026-09-03

Represents DC's optional pharmacist-physician Collaborative Practice Agreement (CPA) tier under § 3-1202.08, not ordinary pharmacist licensure — base dispensing needs no such agreement and is out of scope here. The CPA is elective for both parties and has no independence pathway once entered.

What a District of Columbia Collaborative Practice Agreement must contain

Governed by the DC Board of Pharmacy. Each numbered item is a statutory requirement the agreement must satisfy.

  1. The Pharmacist may enter into a written collaborative practice agreement with the Physician authorizing the Pharmacist to initiate, modify, or discontinue a drug therapy regimen for the Physician's patients, as provided by DC Code § 3-1202.08. The DC Board of Pharmacy and DC Board of Medicine have jointly adopted regulations governing the required form, approval, and revocation of such agreements.

    Source: DC Code § 3-1202.08

  2. District of Columbia law does not require a pharmacist to enter into a collaborative practice agreement in order to hold a pharmacist license or dispense medications generally; the agreement described in this Agreement is required only if the Pharmacist and the Physician elect to engage in the collaborative drug therapy management described above.

  3. The Collaborative Practice Agreement on file also carries 1 scope, 1 registration clauses, generated in the document itself.

Statutes and rules cited

  1. DC Code § 3-1202.08statute

    Authorizes pharmacist-physician collaborative practice agreements to initiate, modify, or discontinue a drug therapy regimen, and directs the Board of Pharmacy and Board of Medicine to jointly issue implementing regulations.

Terms it has to carry

Ratio, proximity, chart review, meeting and prescribing terms the agreement has to carry, from the state's supervision rules.

Proximity

Not codified — left to the agreement

Supervision ratio

Not codified — no cap on file

Chart review

Not codified — left to the agreement

Meeting cadence

Not codified — left to the agreement

Prescriptive authority

Covered by the practice agreement · no controlled-substance authority

Under a CPA, the pharmacist may initiate, modify, or discontinue drug therapy for the physician's patients per the agreement's specified terms (§ 3-1202.08; 17 DCMR Ch. 100/22-B DCMR Ch. 10006) — this is drug-therapy management under a jointly Board of Pharmacy/Board of Medicine-approved protocol, not independent DEA-registered controlled-substance prescribing, so controlledSubstancesAllowed is coded False here; whether CPA terms may extend to controlled substances was not confirmed in this pass.

Written agreement

Required

Only required if the pharmacist and physician elect to engage in collaborative drug therapy management under § 3-1202.08 — a pharmacist's base license and general dispensing authority need no agreement at all.

Practice ownership (corporate practice of medicine)

Non-licensee ownership permitted — No pharmacist-ownership requirement was identified for DC pharmacy permits — not independently confirmed against a specific statute/reg in this pass; treat as consistent with the typical non-restrictive pharmacy-ownership pattern seen in other states rather than a settled DC-specific finding.

Materially more permissive than the healing-arts CPOM regime governing PA/NP/CRNA/CNM/CNS above, if confirmed.

Legal sources for these rules (2)
How the relationship works day to day
Who has to be where, how often you meet, and what the physician costs: Pharmacist in District of Columbia on collaborativeagreement.com.

About District of Columbia's rules

The Health Occupations Revision Amendment Act of 2024 repealed D.C. Code § 3-1206.03, eliminating the collaboration mandate for all APRN categories (NP/PMHNP/CRNA/CNM/CNS) — DC is now a full-practice-authority jurisdiction for APRNs. PAs are NOT covered by that reform and still require a Board of Medicine Delegation Agreement regardless of experience; no autonomous-PA pathway was found in DC as of this pass.

Other clinicians in District of Columbia: see the state overview.